EA200000769A1 - Мутанты il-16, способы их производства и их применение - Google Patents

Мутанты il-16, способы их производства и их применение

Info

Publication number
EA200000769A1
EA200000769A1 EA200000769A EA200000769A EA200000769A1 EA 200000769 A1 EA200000769 A1 EA 200000769A1 EA 200000769 A EA200000769 A EA 200000769A EA 200000769 A EA200000769 A EA 200000769A EA 200000769 A1 EA200000769 A1 EA 200000769A1
Authority
EA
Eurasian Patent Office
Prior art keywords
production
application
mutants
methods
nucleic acid
Prior art date
Application number
EA200000769A
Other languages
English (en)
Russian (ru)
Inventor
Райнхард Курт
Михаэль Байер
Альбрехт Вернер
Доротее Амброзиус
Курт Ланг
Мартин Ланцендёрфер
Original Assignee
Федеративная Республика Германия
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеративная Республика Германия filed Critical Федеративная Республика Германия
Publication of EA200000769A1 publication Critical patent/EA200000769A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EA200000769A 1998-01-24 1999-01-22 Мутанты il-16, способы их производства и их применение EA200000769A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98101232 1998-01-24
PCT/EP1999/000428 WO1999037781A1 (en) 1998-01-24 1999-01-22 Mutants of il-16, processes for their production, and their use

Publications (1)

Publication Number Publication Date
EA200000769A1 true EA200000769A1 (ru) 2001-02-26

Family

ID=8231307

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000769A EA200000769A1 (ru) 1998-01-24 1999-01-22 Мутанты il-16, способы их производства и их применение

Country Status (8)

Country Link
EP (1) EP1049782A1 (es)
JP (1) JP2002500889A (es)
AU (1) AU2424399A (es)
BR (1) BR9907216A (es)
CA (1) CA2320624A1 (es)
EA (1) EA200000769A1 (es)
MX (1) MXPA00006059A (es)
WO (1) WO1999037781A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699466B1 (en) 1999-08-05 2004-03-02 Research Corporation Technologies, Inc. IL-16 antagonist peptides and DNA encoding the peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028134A1 (en) * 1993-05-21 1994-12-08 The Trustees Of Boston University Lymphocyte chemoattractant factor and uses thereof
CA2239704A1 (en) * 1995-12-22 1997-07-03 Bundesrepublik Dutschland, Vertreten Durch Den Bundesminister Fur Gesundheit Polypeptides with interleukin 16 activity, process for the preparation and use thereof
DE19617202A1 (de) * 1996-04-30 1997-11-06 Boehringer Mannheim Gmbh Prozessierte Polypeptide mit IL-16-Aktivität, Verfahren zu ihrer Herstellung und Verwendung
US6444202B1 (en) * 1996-11-25 2002-09-03 Bundesrepublic Deutschland, Vertreten Durch Den Bundesminister Fur Gesundheit Processed polypeptides with IL-16 activity, processes for their production and their use

Also Published As

Publication number Publication date
CA2320624A1 (en) 1999-07-29
WO1999037781A1 (en) 1999-07-29
JP2002500889A (ja) 2002-01-15
BR9907216A (pt) 2000-10-24
EP1049782A1 (en) 2000-11-08
MXPA00006059A (es) 2003-08-01
AU2424399A (en) 1999-08-09

Similar Documents

Publication Publication Date Title
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
ATE293696T1 (de) Mutierte alpha-amylase enzyme mit erhöhter stabilität
AU6329694A (en) Recombinant expression vectors and purification methods for thermus thermophilus DNA polymerase
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DE59711812D1 (de) Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
FI885679A0 (fi) Samuttryckning i eukariotiska celler.
ATE414775T1 (de) Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren
JPS5648884A (es)
Shlyapnikov et al. Primary structure of cytoplasmic aspartate aminotransferase from chicken heart and its homology with pig heart isoenzymes
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
NZ506748A (en) Nucleic acids encoding a GFR alpha 3 polypeptide; host cell and vectors for production of the GRF alpha 3 protein and an assay for detecting GRFalpha 3 production
PT1200561E (pt) Clone celular recombinante estavel, sua producao e utilizacao
DE69735242D1 (de) N-terminal verlängerte proteine exprimiert in hefe
DE69831979D1 (de) Gefrorenes lebensmittel
DK0904356T3 (da) Aspergillus Oryzae 5-aminolevulinsyre-synthaser og nukleinsyrer, der koder disse
EA200000769A1 (ru) Мутанты il-16, способы их производства и их применение
ES2168282T3 (es) D-hidantoinasa recombinante, procedimiento para su preparacion y utilizacion.
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
WO2002008417A1 (fr) Procede de production d'une proteine de recombinaison
DK383984A (da) Fremgangsmaade til fremstilling af sekretin
TR199802168T2 (xx) IL-16 Aktivitesine sahip işlenmiş polipeptidler, bunları üretmeye mahsus yöntemler ve bunların kullanımı.
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
WO2000052133A3 (en) Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same